Envestnet Asset Management
SCPH

Envestnet Asset Management’s scPharmaceuticals SCPH Stock Holding History

Envestnet Asset Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,186
Closed -$92K – 4046
2022
Q3 		$92K Buy
+14,186
New +$75.8K ﹤0.01% 3750
2022
Q2 		– Sell
-10,228
Closed -$58K – 4052
2022
Q1 		$58K Sell
10,228
-2,654
-21% -$13K ﹤0.01% 3849
2021
Q4 		$65K Buy
12,882
+2,186
+20% +$12K ﹤0.01% 3794
2021
Q3 		$71K Buy
+10,696
New +$63.9K ﹤0.01% 3617

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return